Compare RZLT & NATH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | RZLT | NATH |
|---|---|---|
| Founded | 2010 | 1916 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Restaurants |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 420.8M | 413.9M |
| IPO Year | 2011 | 1996 |
| Metric | RZLT | NATH |
|---|---|---|
| Price | $4.47 | $97.46 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 6 | 0 |
| Target Price | ★ $9.67 | N/A |
| AVG Volume (30 Days) | ★ 2.3M | 21.3K |
| Earning Date | 05-13-2026 | 06-09-2026 |
| Dividend Yield | N/A | ★ 1.99% |
| EPS Growth | ★ 26.32 | N/A |
| EPS | N/A | ★ 4.85 |
| Revenue | N/A | ★ $104,201,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $20.11 |
| Revenue Growth | N/A | ★ 7.81 |
| 52 Week Low | $1.07 | $88.67 |
| 52 Week High | $11.46 | $113.59 |
| Indicator | RZLT | NATH |
|---|---|---|
| Relative Strength Index (RSI) | 46.19 | 22.66 |
| Support Level | $2.91 | $89.05 |
| Resistance Level | $4.71 | $97.34 |
| Average True Range (ATR) | 0.32 | 0.91 |
| MACD | -0.11 | -0.40 |
| Stochastic Oscillator | 25.39 | 27.02 |
Rezolute Inc is a clinical-stage biopharmaceutical company focused on developing therapies for rare and metabolic diseases. The company aims to address unmet medical needs in conditions like congenital hyperinsulinism, a rare endocrine disorder causing excessive insulin production and resulting hypoglycemia. Rezolute's pipeline includes drug candidates designed to improve patient outcomes while reducing treatment burdens. The company engages in research, development, and clinical trials to advance its therapies and collaborates with medical communities and patient groups to support its objectives. Revenue and value creation depend largely on successful product development and regulatory approvals.
Nathan's Famous Inc is a branded licensor, wholesaler and retailer of products marketed under its brand. Its products are currently marketed for sale in thousands of locations, including supermarkets, mass merchandisers and club stores, selected foodservice locations and its company-owned and franchised restaurants throughout the United States and in twenty foreign countries. It considers itself to be in the foodservice industry. It has three segments Branded Product Program, Product Licensing, Restaurant Operations, of which majority of revenue is from Branded Product Program which derives from the sale of hot dog products either directly to foodservice operators or to various foodservice distributors. It generates majority of revenue from United States.